Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trial

BACKGROUND: In Canada, the majority of HIV-positive pregnant women receive combination antiretroviral therapy that includes a ritonavir-boosted protease inhibitor to prevent mother-to-child HIV transmission. However, protease inhibitor-based combination antiretroviral therapy has been associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Siou, Kaitlin, Walmsley, Sharon L., Murphy, Kellie E., Raboud, Janet, Loutfy, Mona, Yudin, Mark H., Silverman, Michael, Ladhani, Noor N., Serghides, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153916/
https://www.ncbi.nlm.nih.gov/pubmed/27965866
http://dx.doi.org/10.1186/s40814-016-0087-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153916/
https://www.ncbi.nlm.nih.gov/pubmed/27965866
http://dx.doi.org/10.1186/s40814-016-0087-6

Ejemplares similares